PR
NUVL

PSP Research’s Nuvalent NUVL Stock Holding History

PSP Research’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,261
Closed -$529K – 94
2025
Q4 		$529K Buy
+5,261
New +$519K 0.46% 45

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PSP Research's NUVL Position: Q1 2026 in Review

PSP Research sold out of Nuvalent (NUVL) in Q1 2026, closing a stake of 5,261 shares — an estimated $529K sold.

PSP Research first reported a position in NUVL in Q4 2025 and held it in 1 quarter. The position peaked at $529K in Q4 2025. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • PSP Research reported no remaining Nuvalent position as of Q1 2026 after selling out during the quarter.
  • PSP Research sold 5,261 Nuvalent shares in Q1 2026, an estimated $529K.
  • PSP Research first reported a position in Nuvalent in Q4 2025 and held it in 1 quarter.
  • PSP Research's Nuvalent position peaked at $529K in Q4 2025.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on PSP Research's 13F filing for Q1 2026, filed 17 Apr 2026.